SCHEMBL8851220

SCHEMBL8851220

C[N]CC(=O)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5933082 0.82 LMNA (0.45) —
SCHEMBL30350415 0.82 LMNA (0.45) —
SCHEMBL19231596 0.78 — —
SCHEMBL8851438 0.78 LMNA (0.42) —
SCHEMBL8852292 0.76 LMNA (0.45) —
SCHEMBL15137283 0.75 LMNA (0.39) —
SCHEMBL136589 0.74 — —
SCHEMBL8851727 0.73 LMNA (0.57) —
SCHEMBL17404772 0.73 LMNA (0.38) —
SCHEMBL10674424 0.73 LMNA (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 — — US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 — — EP disclosed
Send feedback